Steve E. Krognes
2020
In 2020, Steve E. Krognes earned a total compensation of $4.3M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
Bonus | $387,362 |
---|---|
Option Awards | $2,018,444 |
Salary | $484,200 |
Stock Awards | $1,364,638 |
Other | $11,400 |
Total | $4,266,044 |
Krognes received $2M in option awards, accounting for 47% of the total pay in 2020.
Krognes also received $387.4K in bonus, $484.2K in salary, $1.4M in stock awards and $11.4K in other compensation.
Rankings
In 2020, Steve E. Krognes' compensation ranked 2,668th out of 13,090 executives tracked by ExecPay. In other words, Krognes earned more than 79.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,668 | 80th |
Manufacturing | 1,024 | 82nd |
Chemicals And Allied Products | 377 | 83rd |
Drugs | 325 | 83rd |
Biological Products, Except Diagnostic Substances | 87 | 79th |
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2020.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019